Lenz Therapeutics Inc (LENZ)

Oct 10, 2025

When is the best time to exit LENZ Therapeutics Inc.Market Movers & Verified Technical Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Using portfolio simulators with LENZ Therapeutics Inc. includedWeekly Trend Report & AI Powered Market Entry Ideas - newser.com

Oct 10, 2025

Oct 10, 2025

Will a bounce in LENZ Therapeutics Inc. offer an exitPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com

Oct 10, 2025

Oct 10, 2025

Piper Sandler raises LENZ Therapeutics stock price target to $67 on VIZZ launch - Investing.com India

Oct 10, 2025

Oct 10, 2025

Weiss Ratings Reiterates Sell (D-) Rating for LENZ Therapeutics (NASDAQ:LENZ) - MarketBeat

Oct 10, 2025

Oct 10, 2025

Visual analytics tools that track LENZ Therapeutics Inc. performance2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Forecasting LENZ Therapeutics Inc. price range with options dataSell Signal & High Yield Stock Recommendations - newser.com

Oct 09, 2025

Oct 08, 2025

Lenz Therapeutics sells $80 million in common stock in block trade By Investing.com - Investing.com Australia

Oct 08, 2025

Oct 08, 2025

Lenz Therapeutics sells $80 million in common stock in block trade - Investing.com India

Oct 08, 2025

Oct 07, 2025

Lenz Therapeutics Announces U.S. Availability of VIZZ Eye Drops for Presbyopia - VisionMonday.com

Oct 07, 2025

Oct 06, 2025

LENZ Therapeutics (NASDAQ:LENZ) Shares Down 3.9%Here's Why - MarketBeat

Oct 06, 2025

Oct 06, 2025

Presbyopia Market Analysis and Forecast Report 2025-2035 Featuring AbbVie, Eyenovia, Entod Pharma, L - PharmiWeb.com

Oct 06, 2025

Oct 06, 2025

Presbyopia Market Analysis and Forecast Report 2025-2035 Featuring AbbVie, Eyenovia, Entod Pharma, Lenz Therapeutics, Orasis Pharmaceuticals, and Tenpoint TherapeuticsResearchAndMarkets.com | FinancialContent - FinancialContent

Oct 06, 2025

Oct 06, 2025

Is LENZ Therapeutics Inc. forming a bottoming base2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Smart tools for monitoring LENZ Therapeutics Inc.’s price actionMarket Growth Review & AI Driven Price Forecasts - newser.com

Oct 06, 2025

Oct 06, 2025

Is LENZ Therapeutics Inc. stock affected by interest rate hikesPortfolio Gains Report & Consistent Profit Trade Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

LENZ Therapeutics’s Valuation: Examining the Impact of VIZZ’s Groundbreaking FDA Approval and US Launch - Sahm

Oct 05, 2025

Oct 05, 2025

What analysts say about LENZ Therapeutics Inc stockOptions Trading Strategies & Small Investment Portfolio Growth - earlytimes.in

Oct 05, 2025

Oct 05, 2025

Chart based analysis of LENZ Therapeutics Inc. trendsJuly 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com

Oct 05, 2025

Oct 05, 2025

Using economic indicators to assess LENZ Therapeutics Inc. potential2025 Price Momentum & Long-Term Safe Return Strategies - newser.com

Oct 05, 2025

Oct 04, 2025

TD Cowen Maintains LENZ Therapeutics(LENZ.US) With Buy Rating, Maintains Target Price $60 - 富途牛牛

Oct 04, 2025

Oct 03, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 03, 2025

Oct 03, 2025

LENZ Therapeutics(LENZ.US) 10% Shareholder Sells US$10.35 Million in Common Stock - 富途牛牛

Oct 03, 2025

Oct 03, 2025

BofA Securities Maintains LENZ Therapeutics(LENZ.US) With Buy Rating, Maintains Target Price $53 - 富途牛牛

Oct 03, 2025

Oct 03, 2025

Will LENZ Therapeutics Inc. stock split attract more investorsMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Vizz Eyedrops Now Available to Improve Near Vision in Adults - Ophthalmology Advisor

Oct 03, 2025

Oct 01, 2025

VIZZ presbyopia eye drops launch in the US - Eyes On Eyecare

Oct 01, 2025

Oct 01, 2025

Companies Like LENZ Therapeutics (NASDAQ:LENZ) Can Afford To Invest In Growth - Yahoo Finance

Oct 01, 2025

Oct 01, 2025

LENZ launches VIZZ eye drops for presbyopia treatment in US By Investing.com - Investing.com Nigeria

Oct 01, 2025

Sep 30, 2025

LENZ Therapeutics Announces Commercial Product Availability of VIZZ in the United States - InvisionMag.com

Sep 30, 2025

Sep 30, 2025

William Blair Maintains LENZ Therapeutics(LENZ.US) With Buy Rating - 富途牛牛

Sep 30, 2025

Sep 30, 2025

LENZ Therapeutics Announces Commercial Product Availability of V - GuruFocus

Sep 30, 2025

Sep 30, 2025

LENZ Therapeutics Says VIZZ 1.44% Presbyopia Eye Drops Available in US - MarketScreener

Sep 30, 2025

Sep 30, 2025

LENZ launches VIZZ eye drops for presbyopia treatment in US - Investing.com India

Sep 30, 2025

Sep 30, 2025

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States - WV News

Sep 30, 2025

Sep 30, 2025

93% Success Rate: LENZ Therapeutics Launches Revolutionary 10-Hour Eye Drops for 128M Adults with Presbyopia - Stock Titan

Sep 30, 2025

Sep 30, 2025

Lenz Therapeutics outlines Q4 2025 launch plans for LNZ100 amid FDA review progress - MSN

Sep 30, 2025

Sep 30, 2025

What drives LENZ Therapeutics Inc stock priceVolatility Trading Techniques & Superior Capital Trading Plans - earlytimes.in

Sep 30, 2025

Sep 30, 2025

Lenz Therapeutics stock hits 52-week high at 44.03 USD By Investing.com - Investing.com Nigeria

Sep 30, 2025

Sep 30, 2025

Is LENZ Therapeutics Inc a good long term investmentVWAP Trading Strategies & Consistent Double Returns - earlytimes.in

Sep 30, 2025

Sep 29, 2025

LENZ Therapeutics (NASDAQ:LENZ) Hits New 12-Month HighHere's What Happened - MarketBeat

Sep 29, 2025